亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

武漢康寶泰精細化工有限公司武昌一分部  

精細化學(xué)品,化工中間體,原料藥

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:付經(jīng)理
  • 電話:027-87738651
  • QQ:664219562
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 367514-88-3 ***魯拉西酮
367514-88-3 ***魯拉西酮
單價 1.00 / 千克對比
銷量 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
庫存 10000千克起訂1千克
品牌 康寶泰
型號 367514-88-3
規(guī)格 25
過期 長期有效
更新 2013-11-25 13:29
 
詳細信息

中文名稱: LURASIDONHYDROCHLORIDE
中文同義詞: 羅西酮***;***魯拉西酮
英文名稱: Lurasidonhydrochloride
英文同義詞: Lurasidonhydrochloride;Lurasidonhydrochlorid;(3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione hydrochloride;(1R,2S,3R,4S)-N-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinylMethyl]-1-cyclohexylMethyl]-2,3-bicyclo[2.2.1]heptanedicarboxyiMide hydrochloride;Latuda, SM 13496;Lurasidone Hydrochlorid
CAS號: 367514-88-3
分子式: C28H36N4O2S
分子量: 492.684
EINECS號: 
相關(guān)類別: Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals
Mol文件: 367514-88-3.mol
熔點  198-205°C
儲存條件  Refrigerator
©2025 武漢康寶泰精細化工有限公司武昌一分部 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:26904  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |